Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura

被引：7
|
作者：
Aggarwal, Asha [1 ]
White, Danielle [2 ]
Pavord, Sue [1 ]
Thomas, Will [2 ]
Desborough, Michael J. R. [1 ,3 ,4 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Oxford, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Haematol, Cambridge, England
[3] Univ Oxford, Radcliffe Dept Med, Oxford, England
[4] John Radcliffe Hosp, Dept Clin Haematol, Headley Way, Oxford OX3 9DU, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 202卷 / 02期
关键词：
daratumumab; plasma cell; refractory; thrombotic thrombocytopenic purpura (TTP);
D O I：
10.1111/bjh.18854
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：429 / 433
页数：5
相关论文
共 50 条
  • [1] Successful treatment with daratumumab for splenectomy refractory immune-mediated thrombotic thrombocytopenic purpura
    Jansen, A. J. Gerard
    Rab, Minke A. E.
    te Boekhorst, Peter A. W.
    Leebeek, Frank W. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [2] Efficacy and safety of daratumumab in multiresistant immune-mediated thrombotic thrombocytopenic purpura
    Weisinger, Julia
    Bouzid, Raida
    Ranta, Dana
    Woaye-Hune, Pascal
    Cohen-Aubart, Fleur
    Gaible, Clotilde
    Marjanovic, Zora
    Corre, Elise
    Joly, Anne-Christine
    Baylatry, Minh-Tam
    Joly, Berangere S.
    Veyradier, Agnes
    Coppo, Paul
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1951 - 1958
  • [3] Daratumumab for frequently relapsing and refractory immune thrombotic thrombocytopenic purpura
    van den Berg, J.
    Hovinga, J. A. Kremer
    Holbro, A.
    Studt, J. -D.
    SWISS MEDICAL WEEKLY, 2021, 151 : 18 - 18
  • [4] Congenital and immune-mediated thrombotic thrombocytopenic purpura
    Hovinga, J. A. Kremer
    HAEMOPHILIA, 2018, 24 : 17 - 17
  • [5] Daratumumab for immune thrombotic thrombocytopenic purpura
    van den Berg, Jana
    Hovinga, Johanna A. Kremer
    Pfleger, Claudia
    Hegemann, Inga
    Stehle, Gregor
    Holbro, Andreas
    Studt, Jan-Dirk
    BLOOD ADVANCES, 2022, 6 (03) : 993 - 997
  • [6] IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA WITHOUT THROMBOCYTOPENIA
    Ul Abedin, Muhammad Shan
    Batool, Izza
    CHEST, 2024, 166 (04) : 2929A - 2930A
  • [7] Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura
    Comparon, Celine
    Galicier, Lionel
    Rebibou, Jean Michel
    Coppo, Paul
    Benhamou, Ygal
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (02) : 157 - 160
  • [8] Laboratory surveillance of immune-mediated thrombotic thrombocytopenic purpura
    Li, Ang
    Hovinga, Johanna A. Kremer
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 82 - 84
  • [9] Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura
    Poullin, P.
    Bornet, C.
    Veyradier, A.
    Coppo, P.
    DRUGS OF TODAY, 2019, 55 (06) : 367 - 376
  • [10] Rituximab in the treatment of immune-mediated thrombotic thrombocytopenic purpura
    Ozpolat, Hasan Tahsin
    Stolla, Moritz
    BLOOD TRANSFUSION, 2023, 21 (05) : 369 - 374
12345